{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:47:37Z","timestamp":1780141657096,"version":"3.54.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800151"],"award-info":[{"award-number":["81800151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571375"],"award-info":[{"award-number":["32571375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570225"],"award-info":[{"award-number":["82570225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>T cell acute lymphoblastic leukemia is a fatal hematological malignancy. Despite the treatment progress, no targeted therapy is available currently, which urges to deepen the understanding of the underlying mechanism of T-ALL cell growth\/survival. Autophagy is a conserved cellular process, which plays a dual role in human cancers. Nevertheless, many aspects of the involvement of autophagy in T-ALL are not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>T-ALL patient cells and normal control cells were subjected to RT\u2012qPCR analysis. Gene silence and overexpression was used to study the function of ATG4B and sestrin 3 (SESN3) in T-ALL cells. Atg4b deficient mice were used to study the role of Atg4b in normal hematopoietic cells and T cell development. The efficacy of S130, an ATG4B inhibitor to suppress T-ALL cell growth was evaluated in xenograft models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed that the expression of several autophagy-related genes (especially\n                      <jats:italic>ATG4B<\/jats:italic>\n                      ) was significantly higher in T-ALL patient cells than control cells. ATG4B ablation decreased autophagic flux and inhibited T-ALL cell growth. In contrast, Atg4b depletion had mild effects on normal hematopoiesis and T cell development. RNA-seq data and subsequent studies revealed a novel regulatory circuit of ATG4B and SESN3, and the results indicated that SESN3 hampered T-ALL cell growth via the inhibition of both mTOR\/S6K\/protein synthesis pathway and autophagy. Importantly, S130 exhibited anti-leukemia activity in xenograft models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study demonstrates that a novel ATG4B-SESN3 regulatory circuit plays a crucial role in T cell leukemogenesis, which suggests that targeting ATG4B is a promising strategy for T-ALL treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03588-0","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:14:55Z","timestamp":1763792095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel regulatory circuit of ATG4B and SESN3 promotes T cell leukemogenesis"],"prefix":"10.1186","volume":"44","author":[{"given":"Wenjuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Qin,","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"10","key":"3588_CR1","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Van Vlierberghe","year":"2012","unstructured":"Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012;122(10):3398\u2013406.","journal-title":"J Clin Invest"},{"issue":"9","key":"3588_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129(9):1113\u201323.","journal-title":"Blood"},{"issue":"16","key":"3588_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541\u201352.","journal-title":"N Engl J Med"},{"issue":"36","key":"3588_CR4","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1200\/JCO.23.01286","volume":"41","author":"R Pieters","year":"2023","unstructured":"Pieters R, Mullighan CG, Hunger SP. Advancing diagnostics and therapy to reach universal cure in childhood ALL. J Clin Oncol. 2023;41(36):5579\u201391.","journal-title":"J Clin Oncol"},{"issue":"14","key":"3588_CR5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2012;30(14):1663\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3588_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2141.2008.07499.x","volume":"144","author":"B Reism\u00fcller","year":"2009","unstructured":"Reism\u00fcller B, Attarbaschi A, Peters C, Austrian Berlin-Frankfurt-M\u00fcnster (BFM) Study Group, et al. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-M\u00fcnster (BFM) Study Group. Br J Haematol. 2009;144(4):559\u201370.","journal-title":"Br J Haematol"},{"issue":"6","key":"3588_CR7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3324\/haematol.2023.283848","volume":"109","author":"BLZ Oh","year":"2024","unstructured":"Oh BLZ, Vinanica N, Wong DMH, et al. Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia. Haematologica. 2024;109(6):1677\u201388.","journal-title":"Haematologica"},{"issue":"4","key":"3588_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1182\/bloodadvances.2023012263","volume":"9","author":"N Maciocia","year":"2025","unstructured":"Maciocia N, Wade B, Maciocia P. CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure? Blood Adv. 2025;9(4):913\u201323.","journal-title":"Blood Adv"},{"issue":"7182","key":"3588_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069\u201375.","journal-title":"Nature"},{"key":"3588_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.biopha.2018.05.007","volume":"104","author":"S Saha","year":"2018","unstructured":"Saha S, Panigrahi DP, Patil S, et al. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother. 2018;104:485\u201395.","journal-title":"Biomed Pharmacother"},{"key":"3588_CR11","doi-asserted-by":"publisher","first-page":"107327482110191","DOI":"10.1177\/10732748211019138","volume":"28","author":"FL Huang","year":"2021","unstructured":"Huang FL, Yu SJ, Li CL. Role of autophagy and apoptosis in acute lymphoblastic leukemia. Cancer Control. 2021;28:10732748211019138.","journal-title":"Cancer Control"},{"issue":"16","key":"3588_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168540","volume":"22","author":"IE Stergiou","year":"2021","unstructured":"Stergiou IE, Kapsogeorgou EK. Autophagy and metabolism in normal and malignant hematopoiesis. Int J Mol Sci. 2021;22(16):8540.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3588_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ijms20030461","volume":"20","author":"K Rothe","year":"2019","unstructured":"Rothe K, Porter V, Jiang X. Current outlook on autophagy in human leukemia: foe in cancer stem cells and drug resistance, friend in new therapeutic interventions. Int J Mol Sci. 2019;20(3):461.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3588_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1084\/jem.20101145","volume":"208","author":"M Mortensen","year":"2011","unstructured":"Mortensen M, Soilleux EJ, Djordjevic G, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med. 2011;208(3):455\u201367.","journal-title":"J Exp Med"},{"key":"3588_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2015.8","volume":"1","author":"AS Watson","year":"2015","unstructured":"Watson AS, Riffelmacher T, Stranks A, et al. Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia. Cell Death Discov. 2015;1:15008.","journal-title":"Cell Death Discov"},{"issue":"23","key":"3588_CR16","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1182\/blood-2013-07-516807","volume":"123","author":"K Rothe","year":"2014","unstructured":"Rothe K, Lin H, Lin KB, et al. The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem\/progenitor cells. Blood. 2014;123(23):3622\u201334.","journal-title":"Blood"},{"issue":"6","key":"3588_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1080\/15548627.2016.1162359","volume":"12","author":"M Karvela","year":"2016","unstructured":"Karvela M, Baquero P, Kuntz EM, et al. ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells. Autophagy. 2016;12(6):936\u201348.","journal-title":"Autophagy"},{"issue":"12","key":"3588_CR18","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood-2015-12-684696","volume":"128","author":"Y Sumitomo","year":"2016","unstructured":"Sumitomo Y, Koya J, Nakazaki K, et al. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood. 2016;128(12):1614\u201324.","journal-title":"Blood"},{"issue":"3","key":"3588_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1046\/j.1365-2141.1997.2623081.x","volume":"98","author":"L Jia","year":"1997","unstructured":"Jia L, Dourmashkin RR, Allen PD, et al. Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol. 1997;98(3):673\u201385.","journal-title":"Br J Haematol"},{"issue":"27","key":"3588_CR20","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1038\/s41388-019-0802-x","volume":"38","author":"J Hounjet","year":"2019","unstructured":"Hounjet J, Habets R, Schaaf MB, et al. The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to \u03b3-secretase inhibition. Oncogene. 2019;38(27):5457\u201368.","journal-title":"Oncogene"},{"issue":"11","key":"3588_CR21","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/leu.2012.136","volume":"26","author":"C Simioni","year":"2012","unstructured":"Simioni C, Neri LM, Tabellini G, et al. Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. Leukemia. 2012;26(11):2336\u201342.","journal-title":"Leukemia"},{"issue":"1","key":"3588_CR22","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41598-024-54400-6","volume":"14","author":"HC Bwanika","year":"2024","unstructured":"Bwanika HC, Leo IR, Struyf N, et al. Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia. Sci Rep. 2024;14(1):4000.","journal-title":"Sci Rep"},{"issue":"1","key":"3588_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2016.01.022","volume":"373","author":"L Zhang","year":"2016","unstructured":"Zhang L, Li J, Ouyang L, et al. Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy. Cancer Lett. 2016;373(1):19\u201326.","journal-title":"Cancer Lett"},{"issue":"9","key":"3588_CR24","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1074\/jbc.M110.199059","volume":"286","author":"M Li","year":"2011","unstructured":"Li M, Hou Y, Wang J, et al. Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem. 2011;286(9):7327\u201338.","journal-title":"J Biol Chem"},{"issue":"2","key":"3588_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/0300985810375810","volume":"48","author":"R Read","year":"2011","unstructured":"Read R, Savelieva K, Baker K, et al. Histopathological and neurological features of Atg4b knockout mice. Vet Pathol. 2011;48(2):486\u201394.","journal-title":"Vet Pathol"},{"key":"3588_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112917","volume":"209","author":"G Yang","year":"2021","unstructured":"Yang G, Li Y, Zhao Y, et al. Targeting Atg4B for cancer therapy: chemical mediators. Eur J Med Chem. 2021;209:112917.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3588_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/cells9010053","volume":"9","author":"A Agrotis","year":"2019","unstructured":"Agrotis A, Ketteler R. On ATG4B as drug target for treatment of solid tumours-the knowns and the unknowns. Cells. 2019;9(1):53.","journal-title":"Cells"},{"issue":"5","key":"3588_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050649","volume":"11","author":"Y Fu","year":"2019","unstructured":"Fu Y, Huang Z, Hong L, et al. Targeting ATG4 in cancer therapy. Cancers (Basel). 2019;11(5):649.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3588_CR29","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1038\/s41598-018-29900-x","volume":"8","author":"D Bosc","year":"2018","unstructured":"Bosc D, Vezenkov L, Bortnik S, et al. A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B. Sci Rep. 2018;8(1):11653.","journal-title":"Sci Rep"},{"issue":"2","key":"3588_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/15548627.2018.1517073","volume":"15","author":"Y Fu","year":"2019","unstructured":"Fu Y, Hong L, Xu J, et al. Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo. Autophagy. 2019;15(2):295\u2013311.","journal-title":"Autophagy"},{"issue":"18","key":"3588_CR31","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/cells13181587","volume":"13","author":"A Haidurov","year":"2024","unstructured":"Haidurov A, Budanov AV. Locked in structure: Sestrin and GATOR-A billion-year marriage. Cells. 2024;13(18):1587.","journal-title":"Cells"},{"issue":"7","key":"3588_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.tibs.2016.04.005","volume":"41","author":"A Ho","year":"2016","unstructured":"Ho A, Cho CS, Namkoong S, et al. Biochemical basis of sestrin physiological activities. Trends Biochem Sci. 2016;41(7):621\u201332.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"3588_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s11658-021-00302-8","volume":"27","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang T, Yu Z, et al. The functions and roles of sestrins in regulating human diseases. Cell Mol Biol Lett. 2022;27(1):2.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3588_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40364-022-00380-6","volume":"10","author":"M Ala","year":"2022","unstructured":"Ala M. Sestrin2 in cancer: a foe or a friend? Biomark Res. 2022;10(1):29.","journal-title":"Biomark Res"},{"issue":"11","key":"3588_CR35","doi-asserted-by":"publisher","first-page":"e78780","DOI":"10.1371\/journal.pone.0078780","volume":"8","author":"E Vakana","year":"2013","unstructured":"Vakana E, Arslan AD, Szilard A, et al. Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cells. PLoS One. 2013;8(11):e78780.","journal-title":"PLoS One"},{"key":"3588_CR36","doi-asserted-by":"crossref","unstructured":"Lin D, Wang D, Li P, et al. Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia. BMC Med Genomics. 2023 26;16(1):13.","DOI":"10.1186\/s12920-023-01442-w"},{"issue":"1","key":"3588_CR37","doi-asserted-by":"publisher","first-page":"e86195","DOI":"10.1371\/journal.pone.0086195","volume":"9","author":"H Zhou","year":"2014","unstructured":"Zhou H, Ge Y, Sun L, et al. Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth. PLoS One. 2014;9(1):e86195.","journal-title":"PLoS One"},{"issue":"20","key":"3588_CR38","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1002\/1878-0261.13306","volume":"16","author":"W Ma","year":"2022","unstructured":"Ma W, Wan Y, Zhang J, et al. Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYC. Mol Oncol. 2022;16(20):3720\u201334.","journal-title":"Mol Oncol"},{"issue":"1","key":"3588_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s11658-023-00496-z","volume":"28","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang Y, Lu J, et al. A conserved ZFX\/WNT3 axis modulates the growth and imatinib response of chronic myeloid leukemia stem\/progenitor cells. Cell Mol Biol Lett. 2023;28(1):83.","journal-title":"Cell Mol Biol Lett"},{"issue":"12","key":"3588_CR40","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood.2022017201","volume":"141","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, Wang D, Lai X, et al. The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease. Blood. 2023;141(12):1474\u201388.","journal-title":"Blood"},{"issue":"3","key":"3588_CR41","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4933","volume":"14","author":"M Piecyk","year":"2024","unstructured":"Piecyk M, Fauvre J, Duret C, et al. SUrface sensing of translation (SUnSET), a method based on western blot assessing protein synthesis rates in vitro. Bio-protocol. 2024;14(3):e4933.","journal-title":"Bio-protocol"},{"issue":"4","key":"3588_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","volume":"19","author":"I Homminga","year":"2011","unstructured":"Homminga I, Pieters R, Langerak AW, et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011;19(4):484\u201397.","journal-title":"Cancer Cell"},{"issue":"11","key":"3588_CR43","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1016\/j.ymthe.2023.09.014","volume":"31","author":"Z Dai","year":"2023","unstructured":"Dai Z, Zhu W, Hou Y, et al. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Mol Ther. 2023;31(11):3225\u201342.","journal-title":"Mol Ther"},{"issue":"1","key":"3588_CR44","doi-asserted-by":"publisher","first-page":"12556","DOI":"10.1038\/s41598-023-39152-z","volume":"13","author":"SS Bhasin","year":"2023","unstructured":"Bhasin SS, Thomas BE, Summers RJ, et al. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis. Sci Rep. 2023;13(1):12556.","journal-title":"Sci Rep"},{"issue":"1","key":"3588_CR45","doi-asserted-by":"publisher","first-page":"e85750","DOI":"10.1371\/journal.pone.0085750","volume":"9","author":"K Yamaguchi","year":"2014","unstructured":"Yamaguchi K, Yamaguchi R, Takahashi N, et al. Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer. PLoS One. 2014;9(1):e85750.","journal-title":"PLoS One"},{"issue":"1","key":"3588_CR46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12935-023-03047-w","volume":"23","author":"X Lin","year":"2023","unstructured":"Lin X, Liu YH, Zhang HQ, et al. DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress. Cancer Cell Int. 2023;23(1):208.","journal-title":"Cancer Cell Int"},{"issue":"33","key":"3588_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau6085","volume":"4","author":"SM Lewis","year":"2019","unstructured":"Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019;4(33):eaau6085.","journal-title":"Sci Immunol"},{"issue":"7020","key":"3588_CR48","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature03029","volume":"432","author":"A Kuma","year":"2004","unstructured":"Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432(7020):1032\u20136.","journal-title":"Nature"},{"issue":"2","key":"3588_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201900099","volume":"42","author":"A Bigas","year":"2020","unstructured":"Bigas A, Guill\u00e9n Y, Schoch L, et al. Revisiting \u03b2-catenin signaling in T-cell development and T-cell acute lymphoblastic leukemia. Bioessays. 2020;42(2):e1900099.","journal-title":"Bioessays"},{"issue":"6","key":"3588_CR50","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/ijc.33527","volume":"149","author":"U Roy","year":"2021","unstructured":"Roy U, Raghavan SC. Deleterious point mutations in T-cell acute lymphoblastic leukemia: mechanistic insights into leukemogenesis. Int J Cancer. 2021;149(6):1210\u201320.","journal-title":"Int J Cancer"},{"issue":"9","key":"3588_CR51","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 2017;129(9):1124\u201333.","journal-title":"Blood"},{"issue":"3","key":"3588_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/BS9.0000000000000073","volume":"3","author":"Q Li","year":"2021","unstructured":"Li Q, Pan S, Xie T, et al. MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies. Blood Sci. 2021;3(3):65\u201370.","journal-title":"Blood Sci"},{"issue":"7","key":"3588_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19071878","volume":"19","author":"C Evangelisti","year":"2018","unstructured":"Evangelisti C, Chiarini F, McCubrey JA, et al. Therapeutic targeting of mTOR in T-cell acute lymphoblastic leukemia: an update. Int J Mol Sci. 2018;19(7):1878.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3588_CR54","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1073\/pnas.1320265111","volume":"111","author":"T Hoshii","year":"2014","unstructured":"Hoshii T, Kasada A, Hatakeyama T, et al. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells. Proc Natl Acad Sci U S A. 2014;111(10):3805\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3588_CR55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ccr.2014.01.032","volume":"25","author":"JS Blackburn","year":"2014","unstructured":"Blackburn JS, Liu S, Wilder JL, et al. Clonal evolution enhances leukemia propagating cell frequency in T cell acute lymphoblastic leukemia through Akt\/mTORC1 pathway activation. Cancer Cell. 2014;25(3):366\u201378.","journal-title":"Cancer Cell"},{"issue":"5","key":"3588_CR56","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/leu.2011.20","volume":"25","author":"C Evangelisti","year":"2011","unstructured":"Evangelisti C, Ricci F, Tazzari P, et al. Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. Leukemia. 2011;25(5):781\u201391.","journal-title":"Leukemia"},{"issue":"6016","key":"3588_CR57","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331(6016):456\u201361.","journal-title":"Science"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03588-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T09:02:24Z","timestamp":1766480544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03588-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3588"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03588-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures conformed to the Helsinki Declaration for the research on humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}